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Allergy to airborne environmental antigens (allergens) is a major cause of asthma in children and
adults. This review argues that the development of allergen-specific immunologic memory of the
type that predisposes to allergy development is the end result of a T-cell selection process
operative during infancy, which is triggered via encounters between the immature immune
system and incoming airborne allergens from the environment. In normal individuals this process
leads to the development of allergen-specific T-memory cells that secure the T helper (Th)-1
pattern of cytokines, which actively suppress the growth of their allergy-inducing Th-2 cytokine-
secreting counterparts. However, these protective allergen-reactive Th-1 memory cells fail to
develop in some individuals, permitting the subsequent proliferation of allergen-specific Th-2 cells
that can trigger allergic reactions. Recent evidence suggests that genetic predisposition to allergy
may be due in part to hyperactivity of control mechanisms operative in utero and which normally
protect the fetoplacental unit against the toxic effect of Th-1 cytokines. Environ Health
Perspect 106(Suppl 3):795-800 (1998). http.//ehpnetl.niehs.nih.gov/docs/1998/Suppl-3/
795-800holt/abstract.html
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Introduction
There is increasing evidence that the
prevalence ofallergic respiratory diseases,
atopic asthma in particular, is currently ris-
ing at an unprecedented rate (1-4). It is
also becoming clear that this rise is largely
restricted to First World countries, to the
extent that it is widely believed to be linked
to Western lifestyle (5,6). A wide range of
environmental antigens, or allergens, have
been identified as eliciting agents, the most
potent ofwhich are found in the indoor
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environment (7). Comparative studies on
populations in the western versus eastern
(formerlysocialist) parts ofGermanysuggest
that this rise in the west commenced in the
late 1950s or early 1960s coincident with
the surge in postwar economic growth,
whereas prevalence rates in the economically
stagnant east remained stable (2), and simi-
lar trends are emerging from studies in
Scandinavia and the Baltic States (2).
Collectively, theseepidemiologic findings
argue strongly that environmental factors
are primarily responsible for the changes
in disease prevalence, and the debate is
intensifying internationally as to the
precise nature ofthese factors. The list of
candidates are legion and include diet,
housing design, population density, and
allergen load in the environment. Parti-
cular interest is focused on air pollution
and respiratory infections and how these
factors interact with the components of
the immunoinflammatory system that are
associated with the manifestations of
allergy (8-10).
To determine how these environmental
factors operate, it is necessary to first gain a
broad understanding of the cellular and
molecular mechanisms underlying the
induction and expression ofallergic reac-
tions; the purpose ofthis review is to high-
light a series of recent advances in this
rapidly moving field. In particular, given
the compelling findings in the current epi-
demiologic literature, which indicate that
these time-related rises in prevalence of
allergic respiratory disease manifest initially
in young children, the principal focus of
this review is the issue ofprimary allergic
sensitization in earlylife.
Why Allergy?
The disease asthma is clearly a multifactorial
process, but there is now an international
consensus that an essential feature of the
disease is inflammation of the airway
mucosa. The latter may be triggered by
chemical irritants, virus infection [partic-
ularly in infants with small airways (11)],
or environmental allergens (12). All of
these factors are potentially interactive; in
particular, allergic asthma can be exacer-
bated by viral infection (13,14) or air
pollutants (15).
However, seroepidemiologic studies on
large populations indicate a strong correla-
tion between serum titers ofimmunoglob-
ulin (Ig)E (the allergic antibody) and the
manifestation ofasthma in all age groups
(16), which points to allergy as a major
determinant ofthe asthmatic phenotype.
In this context, it is also ofinterest to note
that recent comparative studies on the
immunopathology ofatopic (allergic) ver-
sus intrinsic (of hitherto unknown etiol-
ogy) asthma have demonstrated virtually
identical immunoinflammatory infiltrates
in airway biopsy samples from patients
with these two forms ofthe disease (17).
Allergy Effector Mechanisms:
Induction and Regulation
Allergic reactions are the result ofa cellular
cascade that occurs over a distinct biphasic
time scale. The initial or immediate phase
ofallergy occurs within seconds to minutes
of encountering an antigen (namely, an
allergen) to which the subject has
previously been sensitized. The allergen
becomes bound to a specific IgE antibody
attached to the surface ofmast cells, which
are abundant in tissues at the body's muco-
sal surfaces. The formation ofIgE-allergen
complexes on the surface ofthe mast cells
triggers the rapid release of intracellular
granules containing edema-inducing
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vaso-active amines such as histamine,
causing local swelling that (if it occurs in
the airways) can result in bronchoconstric-
tion. This immediate response is followed
by the slower release from mast cells of
other classes ofbioactive molecules, in par-
ticular cytokines and chemokines, which
recruit other cell types into the inflamed
tissue site. This second wave of cells, in
particular T lymphocytes and eosinophils
(18), steadily accumulates over the next 6
to 12 hr, becomes activated, and releases a
different range ofinflammatory mediators,
provoking a late phase response that can
result in more severe and prolonged
bronchoconstriction in the airways than is
seen in the acute phase.
This inflammatory cascade also
involves contributions from platelets,
polymorphonuclear leukocytes, basophils,
monocytes, macrophages, and dendritic
cells, and parallel contributions from
acellular inflammatory elements such as
the complement system.
However, there is one cellular mecha-
nism that is an absolute prerequisite for
the manifestation of allergic reactivity,
namely, the development ofT-lymphocyte
responsiveness to the allergen. These T
lymphocytes determine the level of
involvement of the most potent cellular
mediators of allergic tissue damage, mast
cells and eosinophils, in the host response.
They regulate the former by secretion of
the cytokine interleukin (IL)-4, which
controls the synthesis ofthe IgE antibodies
that arm mast cells, and they also regulate
eosinophils through production of IL-5,
the principal cytokine that controls
eosinophil differentiation and activation
(19,20). Unless T lymphocytes that have
become sensitized (i.e., immune) to environ-
mental allergens are present and can thus
respond upon subsequent allergen reexpo-
sure by secretion ofIL-4 and IL-5, allergic
reactions cannot be initiated.
Hence, the principal focus ofimmuno-
logic research in the asthma and allergy
area has progressively turned toward the
issue of T-cell reactivity to allergens, in
particular the question ofhow sensitivity
to different classes of environmental aller-
gens encountered at the body's mucosal
surfaces is programmed into long-term
immunologic memory.
Regulation ofT-Cell Immunity
at Mucosal Surfaces: Insight
from Experimental Models
The host response to low-level antigen
exposure at mucosal surfaces is regulated
via the immunologic equivalent of the
yin-yang principle, as described in Figure 1
(19,20). The response is initiated by spe-
cialized antigen-presenting dendritic cells
(DCs), which are distributed as a tightly
meshed network within the epithelium
overlying the body's mucosas, in particular
in the respiratory tract (21-23). Their
function is to sample incoming inhaled
antigens and transport them to regional
lymph nodes for presentation to T lympho-
cytes (23,24). In the scheme detailed in
Figure 1, the initial T lymphocyte stimu-
lated is an immunologically naive precursor
(T helper-O [Th-O]) bearing a receptor that
is capable of recognizing DC-bound anti-
gen. This recognition event triggers the Th-
O cell into clonal expansion down one of
two optional differentiation pathways, the
choice ofwhich is determined by the bal-
ance ofcytokines present in the surround-
ing milieu. Th-0 cells automatically secrete
low levels ofIL-4 following initial stimula-
tion (25), and in the absence of counter-
manding signals, this cytokine promotes
the differentiation ofTh-O into T helper
(Th)-2 cells, which (in the mouse) secrete
IL-4, IL-5, and IL-10. However, ifsignifi-
cant levels ofother cytokines that can coun-
teract the effects of IL-4 are present (in
particular IL-12 from nearby macrophages
or activated DCs, or interferon [IFN] from
cytotoxic T cells or natural killer cells
[Figure 1]), the differentiation ofTh-O cells
may be pushed toward the Th-1 pheno-
type, which all are major producers ofIFN-
y. Downstream of these initial events, a
further level ofcompetitive cross-regulation
occurs between growing clones ofTh-1 and
Th-2 cells, involving the secretion ofTh-2-
inhibitory IFN-~ybyTh-1 cells and secretion
ofTh-1-inhibitory IL-10 byTh-2 cells.
Eventually, one of these mutually
antagonistic Th-cell phenotypes gains
dominance in the developing immune
response, progressively locking out its com-
petitors (26). This lock is programmed
into long-term immunologic memory and
is reinforced at each subsequent exposure
via the preferential stimulation ofthe dom-
inant Th-cell phenotype. This overall
process is known as immune deviation.
In such a scheme, if initial immune
responses to an inhaled environmental aller-
gen led to the selection ofTh-2 memory
cells, subsequent reexposures would progres-
sively expand the number ofthese cells at
the periphery, stimulating increasingly more
vigorous IL-4- and IL-5-dependent IgE,
mast cell, and eosinophil responses of the
type associated with allergy. Conversely, if
the response was initially polarized toward
the selection ofIFN-y-secreting Th-1 mem-
ory cells, reexposure would stimulate the
production ofIgA and IgG subclass anti-
bodies, which assist in rapid clearance of
allergen from the body, thus minimizing
involvement from inflammatorycells.
Regulation of immune responses to
environmental allergens encountered at
mucosal surfaces in the gastrointestinal
tract involves immune deviation, but in
situations where high concentrations offood
allergens are involved, a second series of
control mechanisms becomes operative,
which results in the clonal deletion of
Respiratory infection
Figure 1. Cytokine-driven selection of alternate forms of allergen-specific immunologic memory via immune
deviation.
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responder T lymphocytes (27). The tandem
operation ofthese two regulatory processes
summate to the phenomenon oforal toler-
ance, which is believed to be the principal
mechanism that protects against food allergy
and associated immunologic enteropathies.
It is of interest to note that both oral
tolerance and its respiratory tract equiva-
lent function poorly in newborn animals,
and that these mechanisms do not become
fully functional until around the time of
weaning (27).
Regulation ofT-Cell
Immunityto Environmental
Allergens in Humans:
Application ofthe Murine
Th-1 and Th-2 Paradigm
Research over the last 6 to 7 years, in
particular in the area ofT-cell cloning, has
established that it is the nature ofan indi-
vidual's immune responsiveness to envi-
ronmental allergens, as opposed to the
expression ofactive T-cell immunity per se,
that determines clinical responder pheno-
type. Thus, individuals expressing allergy
to antigens such as pollens (e.g., as rhinitis
or bronchial asthma) contain circulating
pollen-reactive T cells that can be isolated
by cloning techniques and that upon in
utero stimulation with the same allergen
will secrete Th-2 cytokines such as IL-4
and IL-5. In contrast, nonallergic individu-
als contain allergen-reactive T cells that
respond via secretion ofTh-1 cytokines
such as IFN-y, with little accompanying
IL-4 or IL-5 activity (28,29). These differ-
ences are not necessarily absolute, but
instead reflect the nature ofequilibrium in
respective immune responses, i.e., allergen-
specific responses in atopics are dominated
by Th-2 cytokines, whereas Th-1 cytokines
are dominant in the same responses in nor-
mals. This presumably indicates the rela-
tive frequency ofTh-1 and Th-2 cells in
respective Th memory compartments.
Allergen-Specific T-Helper
Memory Development in
Humans: How and When?
The evidence from animal model systems
suggests that the key events determining
the nature ofT-cell memory to mucosally
presented allergens occur at or around the
time of the first few exposures. Accord-
ingly, there is increasing interest in the
nature ofallergen-specific T-cell immunity
to these antigens during infancy and early
childhood, the period during which the
human immune system ostensibly first
encounters these agents.
Recent studies reviewed by Holt (27)
demonstrate that IgG and IgE antibody
production against food and inhalant aller-
gens is indeed initiated during infancy,
which pinpoints this life period as a crucial
phase in the process underlying develop-
ment ofallergic disease. Prospective cohort
studies examining both antibody (29) and
T-cell lymphoproliferative responses (30)
suggest that repeated exposure to environ-
mental allergens during this period stimu-
lates a variety ofdifferent T-cell regulatory
mechanisms depending on the levels of
allergen exposure. Notably, high-dose
exposure to food allergens appears to trig-
ger high-zone tolerance mechanisms, lead-
ing in most individuals to the efficient
deletion ofthe bulk offood allergen-spe-
cific T cells. In contrast, exposure levels to
inhalant allergens are 1 to 2 orders ofmag-
nitude lower and instead preferentially trig-
ger immune deviation mechanisms that
select for allergen-specific Th-2 memory
cells in atopics or Th-1 memory cells in
normals (27,30,31).
On this basis, respiratory allergy
(including atopic asthma) can be viewed as
a failure ofthe immune deviation mecha-
nisms that should normally select for Th-1
memory cells during these allergen-driven
immune responses in early life. The reason
for the disparity between atopics and nor-
mals is unknown, but tantalizing hints as to
the nature ofthe underlying Th-cell selec-
tion mechanisms have appeared in the very
recent literature (32,33), in particular that
relating to the immunologyofpregnancy.
Work from a number of groups
[reviewed by Wegmann et al. (32) and
Mosmann and Sad (33)] has now estab-
lished that the cytokine milieu at the feto-
maternal interface is constitutively skewed
away from the Th-1 phenotype. This appar-
ently represents an evolutionary adaptation
designed to protect the integrity ofthe feto-
placental unit, which is exquisitely sensitive
to the toxic effects ofTh-1 cytokines such as
IFN-y (34,35). One ofthe major mecha-
nism(s) underlying this process involves the
constitutive secretion ofTh-2-selective
cytokines such as IL-4 and IL-10 by placen-
tal cells (32,33)-trophoblasts in particular
(36). This blanket ofTh-2 cytokines has
the effect ofskewing neonatal responses
towards selection forTh-2 memorycells.
It is also evident that this Th-2 skew is
maintained for varying periods postnatally,
as infant mice display preferential expan-
sion of Th-2 memory cells during the
preweaning period (37,38). Indirect
evidence strongly suggests that the same
situation applies in humans. It is widely
recognized that peripheral blood leukocytes
(PBL) from human infants display poor
IFN-y-secreting capacity, which can persist
for up to 5 years postnatally (39).
The Sensitization Window
during Infancy
It is offurther interest to note that infant
(40) and neonatal (41-43) PBL from sub-
jects with atopic family history manifest
significantly lower IFN-y-secreting capacity
than their family history negative counter-
parts, suggesting that hyperactivity ofthe
mechanism(s) responsible for maintenance
of the Th-2 skew during fetal life may be
inherent in the atopic genotype.
This provides an explanation for one of
the enigmas ofthe allergyliterature, notably
the existence of a transient high-risk
window for allergic sensitization during
infancy. The latter concept derives from a
wide body ofepidemiology demonstrating
that exposure to relatively high levels of
inhalant allergens during the first few
months oflife (exemplified by birth dur-
ing the pollen season) is associated with
markedly increased risk for expression of
allergic respiratory disease in response to
exposure to the same allergens in adult life
(2,44), particularly in infants with positive
atopic family history (45). These findings
are not universally accepted, as some studies
suggest that the highest risk is associated
with birth 2 to 3 months before the peak
of the pollen season (46), whereas others
have failed to detect such relationships
(47). However, it has been argued that
these contrasting findings may be due to
variations in the degree offluctuation in
aeroallergen levels throughout the year in
different geographical areas.
In the context ofthe manystudies where
birth-month effects have been detected, it
can be argued that initial exposure ofnew-
borns to high levels ofenvironmental aller-
gens at a time when their immune systems
are still partially locked into the Th-2-
skewed cytokine phenotype characteristic of
fetal life would maximize the likelihood of
development ofpotentially pathogenic Th-
2-skewed allergen-specific Th-cell memory.
Furthermore, this risk may be highest in
infants of the atopic genotype, in whom
the perinatal Th-2 skew appears strongest.
Evidence is also emerging that this risk
may be further amplified via prenatal aller-
gen exposure. Reports from several indepen-
dent laboratories suggest that initial priming
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of the fetal immune system against
environmental allergens can occur in utero
in many instances (30,42,48-50), possibly
via transplacental transport ofallergen-
specific IgG antibody and low levels of
native or processed allergen from the mater-
nal circulation (30). Moreover, recent work
from our laboratory indicates that these
early T-cell responses are dominated by
Th-2-selective cytokines, in particular
IL-10 (51).
Cellular Mechanism(s)
Underlying theTh-2
Skew during Infancy
A further series ofpublications during the
last year from yet another area ofthe peri-
natal immunology literature has provided
further insight into this process and may
prove to be a majorwatershed in the allergy
and asthma literature. These publications
concern the phenomenon ofneonatal toler-
ance, an experimental system that has been
studied extensively since the 1960s and has
provided much of the theoretical back-
ground to our current understanding of
discrimination between self and nonself
antigens in the immune response.
The basis for this phenomenon was
believed to be a general hyporesponsive-
ness of the immature immune system in
neonates to parenteral immunization with
foreign antigen. This maturational defect
is not absolute, as demonstrated by the
positive antibody responses to infant vacci-
nation observed in both experimental ani-
mals and humans. However, recent studies
indicate significant qualitative differences
between the same responses in infants and
adults. Indeed, in a variety ofexperimental
systems, neonatal experimental animals
thus immunized develop tolerance to the
antigen, characterizeed by an apparent fail-
ure to recognize the antigen if it is pre-
sented to them subsequently during
adulthood. It was generally believed that
some malfunction in the immature neona-
tal immune system led to the clonal dele-
tion of the T cells that responded to the
antigen at the time of initial immuniza-
tion. However, the assay systems that have
been used to test responses in ostensibly
tolerant mice were almost exclusively
Th-1-dependent, e.g., IgG production,
delayed-type hypersensitivity response,
graft versus host response, etc. What in fact
occurs is that neonatal priming triggers
low-level Th-2 memory cell development
because ofthe covert operation ofthe fetal
Th-2-skewing process described above.
Upon subsequent rechallenge with the
same antigen in adulthood, the neonatally
primed Th-2 memory cells are activated
and lock out Th-1 responses via immune
deviation (52,53).
Importantly, the step in the immune
response in infant mice at which this lock
out occurs has been narrowed down to a
singular cellular locus involving the activity
ofthe antigen-presenting cells (APC) that
initiate T-cell activation (52). The princi-
pal APC population responsible for stimu-
lating primary immune responses involving
Th-0 cells is the DC. In immunocompe-
tent adults, DCs preferentially stimulate
Th-1 memory cell development, but in
infants they lack this capacity and instead
promote Th-2 responses. Iftheir activity is
bypassed by adoptive immunization of
newborns with antigen-pulsed syngeneic
adult DCs, the ensuing immune response
leads to adult-equivalent Th-1 memory
development (52).
The precise nature of the functional
differences between adult and neonatal DC
remains to be established. A likely candi-
date is capacity for production of IL-12,
the principal cytokine employed by adult
DCs for positive selection ofTh-1 memory
cells [(54,55); Figure 1], and our labora-
tory is currently focusing on this question
in relation to human neonatal DCs.
It is also interesting to note in this
context that the reduced capacity of
human infant T cells to secrete IFN-y in
response to polyclonal stimulation can be
partially corrected by supplementation of
the cultures with maternal peripheral blood
accessory cells (56,57), which again sug-
gests that the general findings in the mouse
model are likely to be broadly applicable
to humans.
In relation to infant immune responses
to the airborne environmental allergens
associated with atopic asthma, the relevant
APC population involved in Th memory
development is the airway intraepithelial
DC described above (21-23). This net-
work is functionally deficient in rats during
infancy and develops functional compe-
tence at a slower rate than DCs in other
mucosal or lymphoid compartments, hint-
ing at an important role for local tissue fac-
tors in the maturation process (39,57).
Local tissue inflammation appears to be one
factor that hastens postnatal maturation of
these cells (56).
Conclusions
It is becoming increasingly clear that in
many individuals the expression ofallergic
diseases such as atopic asthma is attribut-
able to immunologic errors occurring dur-
ing infancy, which result in inappropriate
selection for allergen-specific Th-2 memory
cells. It is also likely that a common cause
ofsuch errors may be the sluggish postna-
tal maturation ofthe Th-1-selective func-
tions ofAPC, in particular airway mucosal
DC populations.
The prime function ofDCs is believed
to be generation ofprotective Th-1 immu-
nity against microbial pathogens presented
at mucosal surfaces (52,58). Breakdown
products of the pathogens themselves
(especially bacterial lipopolysaccharides)
provide one of the major stimuli for
DCs to secrete the potent Th-1-selective
cytokine IL-12.
The second major stimulus for IL-12
production by DCs is interaction with
CD40 ligand on the surface ofactivated T
cells. However, neonatal and infant T cells
are deficient in CD40 ligand expression
(59), and hence in the absence ofstrong
signaling via CD40 ligand, IL-12 produc-
tion by DCs in early life may be more
dependent on microbial stimulation than is
the case in adulthood. This may account in
part for the apparent protective effects of
respiratory infections in early life in rela-
tion to subsequent allergy development,
and in turn for some ofthe differences in
prevalence ofasthma and atopy related to
geographyand social class (2,3,8-10).
To what extent can these new findings
be usefully applied to primary prevention
ofallergic respiratory diseases? At present
this question remains within the realms of
research, but a variety ofnovel strategies
based on these concepts are currently under
development in several centers.
Thesestrategies indude: inhalantallergen
avoidance measures aimed at limiting aller-
gen exposure during the period ofearly
infancy in which the fetal Th-2 skew is
most marked; development ofpharmaco-
logic adjuvant strategies that aim to mimic
the DC-stimulatory effects of microbial
agents without the attendant tissue damage
caused byinfections; and immunotherapeu-
tic intervention in allergen-specific immune
responses during infancy to directly stimu-
late Th-1 memory development via a
vaccinelike approach (60).
The alarming upward trend in the
prevalence ofatopic respiratory disease in
our communities, and the spiraling costs of
associated health care, provide urgent
imperatives for the vigorous pursuit of
these and related strategies for primary
disease prevention.
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